Member Info for silverhorse

“Nobody else has this data. Nobody else has this challenge data to analyze. So I think this is where Poolbeg is unique.” - Very good times ahead !

It’s ripe for a partnership deal and the team at Poolbeg has allowed and are continuing to let the industry know about it at big biotech events throughout the year that chief executive Jeremy Skillington calls “partnering conferences” including recent ones in Dublin, Leuven and Boston. There’s no rush though stresses Skillington as “it is our Crown Jewels. Prize assets. So we’re going to be very careful with who we partner with there, but we see multiple paths forward here.”

Poolbeg noted the data set had previously identified drug targets, specifically p38 MAP kinase which Poolbeg’s POLB 001 treatment has proved effective in targeting, but used manual analysis that took several years. Using AI, that was cut to 15 months, and multiple targets were identified. The analysis also backed up the POLB 001 treatment programme by independently confirming the significance of the p38 MAP kinase pathway in influenza.

Got 1k 8.47euros - We will likely stay at this price for a few weeks - BAN SHORTING !

The short is working now - started 9.15 but unlikely to fall much under 8.50euros - when they buy back it will fly over 10euros again - more profits results 31july buy

In december HVO was 10p i was going to buy alot it went up to 25p - same will happen here!

Interesting trades - bit like POLB my other star buy - who will double first 0.80 here POLB 18p i think here but for certain 15p there - Very positive is coming

Fair value 15p at the moment

Sinéad Bleiel, founder and chief scientific officer of AnaBio Technologies, added: “Having demonstrated the potential of our encapsulation technology to deliver drug products safely and effectively to the gut, we are excited to collaborate with the EncOVac team of world class researchers, led by Poolbeg and supported by the Irish Government as part of the world’s renewed fight against infectious diseases.” This got me on the hook at the start - Takeover if all goes well

Short closing

This will more then double very easy - 30p TP

Over 9p soon - probably a update tomorrow before the big news - so certain

The team Jeremy Skillington, PhD, Ian O'Connell & David English look forward to meeting with industry colleagues at the BIO International Convention.

📍 Boston, MA

📅5-8 June 2023

💬#POLB 001, #AI programmes & our exciting pipeline

Around 9.15euros - They are doing a big attack now it will fail so funny

It will probably close out very soon

That explains it now -why we are not over 10euros, with the buyback going on and profits set to rise alot more - that short position will fail, the last short was 2euros remember - very strange thinking this time

Holding good around 8.99euros - Very confident it will go over 11euros before 15aug. As john says low target 11.70euros - happy days if over 12euros

Last time to buy under 10p this week -

Hi Cashintime - Good post. So much is going on i expect big news that we move us on a new level - no more under 10p for certain!

Neutral means that the trend is undetermined. They probably mean if all goes to plan - peace, booming economy 12.71euros